SCHEMBL1366351

SCHEMBL1366351

Cc1ccc2[nH]c(=O)c(C(=O)c3cc4cc(C)ccc4[nH]c3=O)cc2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DAO P14920 2/20 0.65
▸ KDM4E B2RXH2 8/20 0.58
▸ ALDH1A1 P00352 8/20 0.58
▸ HSD17B10 Q99714 5/20 0.58
▸ PIN1 Q13526 1/20 0.56
▸ FLT3 P36888 3/20 0.54
▸ PDGFRB P09619 1/20 0.54
▸ PDGFRA P16234 1/20 0.54
▸ CA12 O43570 1/20 0.51
▸ CA9 Q16790 1/20 0.51
▸ POLB P06746 2/20 0.51
▸ GAA P10253 2/20 0.51
▸ HPGD P15428 4/20 0.50
▸ MAPT P10636 2/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ ALOX15 P16050 1/20 0.49
▸ CASP1 P29466 1/20 0.49
▸ CASP7 P55210 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10969986 0.88 KDM4E (0.66) DAOKDM4EALDH1A1HSD17B10PIN1
SCHEMBL12082628 0.84 ALDH1A1 (0.61) DAOKDM4EALDH1A1HSD17B10PIN1
SCHEMBL22223088 0.84 DAO (0.58) DAOKDM4EALDH1A1HSD17B10PIN1
SCHEMBL4344151 0.81 FLT3 (0.61) DAOKDM4EALDH1A1FLT3PDGFRB
SCHEMBL15564491 0.81 DAO (0.54) DAOKDM4EALDH1A1HSD17B10PIN1
SCHEMBL4649667 0.79 DAO (0.52) DAOKDM4EALDH1A1HSD17B10PIN1
SCHEMBL1366008 0.79 KDM4E (0.48) DAOKDM4EALDH1A1HSD17B10FLT3
SCHEMBL1368448 0.79 DAO (0.65) DAOKDM4EALDH1A1HSD17B10FLT3
SCHEMBL1367967 0.79 DAO (0.65) DAOKDM4EALDH1A1FLT3POLB
SCHEMBL16767844 0.79 DAO (1.00) DAOKDM4EALDH1A1HSD17B10PIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 — — US claimed
WO-2006132947-A2 3-ACYL COUMARINS, THIOCHROMONES AND QUINOLONES AND THERAPEUTIC USES THEREOF TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2006-12-14 — — WO claimed
US-8067461-B2 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-11-29 — — US disclosed
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 — — US disclosed
WO-2006132947-A2 3-ACYL COUMARINS, THIOCHROMONES AND QUINOLONES AND THERAPEUTIC USES THEREOF TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2006-12-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof NQO2, NQO1, HCCS DAO 3402/4885KDM4E 2293/4885ALDH1A1 617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback